2. In this Part “cyanogenic substances” means preparations which—U.K.
(a)are presented for sale or supply under the name of, or as containing, amygdalin, laetrile or vitamin B17; or
(b)contain more than 0.1 per cent by weight of any substance having the formula either—
(i)alpha-Cyanobenzyl -6-O-Beta-d-glucopyranosyl -Beta-d-glucopyranoside, or
(ii)alpha-Cyanobenzyl -Beta-d-glucopyranosiduronic acid.